Mainland China APAC News & Press Release Distribution

Ping An CIO Benjamin Deng: Maintaining a "Double Barbell" Asset Allocation Strategy, Seeing Potential in Investment Opportunities Brought by Energy Transition

HONG KONG and SHANGHAI, June 4, 2024 /PRNewswire/ -- China's macroeconomy and capital market development remains steady this year, andPing An will maintain a balanced "double barbell" asset allocation to ensure stable returns, said Benjamin Deng, Chief Investment Officer of Ping An Insurance (Grou...

2024-06-04 17:16 2933

COP28 Presidency calls for global effort to leverage the rise of AI, the energy transition and the growth of the Global South to accelerate sustainable development for all

BAKU, Azerbaijan, June 4, 2024 /PRNewswire/ -- COP28 President Dr. Sultan Al Jaber today told delegates at the opening of the Baku Energy Week that all stakeholders need to leverage the rise of Artificial Intelligence (AI), the energy transition and the growth of the Global South to accelerate cl...

2024-06-04 16:53 2123

Intersolar Europe 2024: Discover Hiconics' Innovative Residential Green Energy ODM Solution

Hiconics' world-class proprietary ODM supply chain has forged a path for high-quality product delivery. MUNICH, June 4, 2024 /PRNewswire/ -- Hiconics Eco-energy Technology ("Hiconics"; SHE300048), a green energy brand under the Midea umbrella, i...

2024-06-04 16:29 1828

Intersolar Europe 2024: Discover Hiconics' Innovative Residential Green Energy ODM Solution

SANY Leads Industry's Low-Carbon Development with Market Volume of Over US$400 Million

SHANGHAI, June 4, 2024 /PRNewswire/ -- Leading Chinese heavy equipment manufacturer SANY Group ("SANY") has reported that its total revenue of electric products reached3.146 billion yuan (US$434.78 million) in 2023, with hydrogen energy products achieving130 million yuan (US$17.97 million) in re...

2024-06-04 13:07 2017

SANY Leads Industry's Low-Carbon Development with Market Volume of Over US$400 Million

TECNO showcases its AIoT ecosystem with Multiple forms PC at COMPUTEX 2024 Centering on "Smart of Creation"

Step into the future with TECNO's latest AI-enhanced innovation, the Dynamic 1 robotic dog,PocketGo, Mini PCs, MEGABOOK Series and AI-empowered CAMON 30 Premier 5G at Computex 2024. TAIPEI, June 4, 2024 /PRNewswire/ -- Innovative technology brand TECNO today stunningly showcased its ecosyst...

2024-06-04 12:01 15477

TECNO showcases its AIoT ecosystem with Multiple forms PC at COMPUTEX 2024 Centering on

RemeGen Reports Proof-of-Concept Phase I/II Clinical Study Results for Self-Developed, Potential First-in-Class Antibody-Drug Conjugate RC88

YANTAI, China, June 4, 2024 /PRNewswire/ -- RemeGen Co., Ltd. ("RemeGen" or "the Company") (9995.HK, SHA: 688331), a commercial-stage biotechnology company, presented the results of the first-in-human, single-arm, open-label, multi-center Phase I/II study evaluating RC8...

2024-06-04 09:38 1574

YCYW Held Seminar on the Trailblazing Journey of ECE Practice

BEIJING, June 3, 2024 /PRNewswire/ -- On 30 May, in Beijing, the Yew Chung Yew Wah Education Network (YCYW) held a seminar on "Exploring the Trailblazing Journey of Early Childhood Education Practice", and launched the simplified Chinese version ofThe Yew Chung Approach to Early Childhood Educati...

2024-06-03 17:45 2444

YCYW Held Seminar on the Trailblazing Journey of ECE Practice

Trinasolar Releases Sustainability Report for 2023, Detailing its Commitment, Action and Achievements Towards a More Sustainable World

CHANGZHOU, China, June 3, 2024 /PRNewswire/ -- Trina Solar Co., Ltd. (688599. SH), one of the world's leaders in smart PV and energy storage solutions, recently released its2023 Sustainability Report ...

2024-06-03 17:43 1998

First Park Hyatt hotel in central China opens in the vibrant city of Changsha

CHANGSHA, China, June 3, 2024 /PRNewswire/ -- Park Hyatt Changsha opens today, marking the debut of the Park Hyatt brand in the heart of centralChina's Hunan capital. A...

2024-06-03 14:45 1644

First Park Hyatt hotel in central China opens in the vibrant city of Changsha

Shandong Liaocheng Power Supply Company of State Grid: "Family-Like Service" Empowers the Preservation of Intangible Cultural Heritage

LIAOCHENG, China, June 3, 2024 /PRNewswire/ -- "The entire process of producing tribute bricks is now intimately connected with the use of electricity, increasing our requirements for power. Thankfully, your frequent inspections at our base ensure we no longer worry about the safety of our electr...

2024-06-03 13:45 1536

GOODYEAR'S HOPE SHINES BRIGHT: EMPOWERING FUTURES IN TIEXI

SHANGHAI, June 3, 2024 /PRNewswire/ -- Goodyear commemorated the first anniversary of its Hope School in Tiexi, Dalian Pulandian,China. This corporate responsibility program underscores the company's enduring commitment to build and support programs that create positive outcomes for people and co...

2024-06-03 12:08 1666

GOODYEAR'S HOPE SHINES BRIGHT: EMPOWERING FUTURES IN TIEXI

Alphamab Oncology Presented Chinese Clinical Data of Anti-HER2 Bispecific ADC JSKN003 for the First Time at the 2024 ASCO Annual Meeting

* Results from the phase I part of JSKN003-102 was reported at this ASCO Annual Meeting. * JSKN003 exhibited a favorable tolerability and manageable safety profile in heavily pretreated patients with advanced/metastatic solid tumors and demonstrated encouraging antitumor activity during dose ...

2024-06-03 10:17 1756

Inspur Group Making Its Debut at the 2024 Asia Tech x Singapore (ATxSG)

SINGAPORE , June 3, 2024 /PRNewswire/ -- The 2024 Asia Tech x Singapore (ATxSG) exhibition, held inSingapore, opened with great fanfare from May 29th to 31st, 2024. Inspur Group has been invited to participate and held presentation campaigns to showcase their significant technological products, s...

2024-06-03 10:03 2014

Innovent Delivers Oral Presentation of Clinical Data of A Randomized Controlled Phase 1b Study Evaluating IBI310 (Anti-CTLA-4 Monoclonal Antibody) in Combination with Sintilimab as Neoadjuvant Treatment of Colon Cancer at 2024 ASCO Annual Meeting

SAN FRANCISCO and SUZHOU, China, June 3, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune, ophthalmology and ot...

2024-06-03 09:44 2251

Innovent Delivers Oral Presentations at the 2024 ASCO Annual Meeting on Clinical Data of First-in-Class anti-CLDN18.2/CD3 Bispecific Antibody (IBI389) for the Treatment of Advanced Pancreatic Cancer and Gastric Cancer

SAN FRANCISCO and SUZHOU, China, June 3, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune...

2024-06-03 09:35 2774

Innovent Announces Taletrectinib（ROS1 Inhibitor）Updated Data from Pivotal Phase 2 TRUST-I Study of are Published in the JCO and Orally Presentedat 2024 ASCO Annual Meeting

SAN FRANCISCO and SUZHOU, China, June 2, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune,...

2024-06-02 13:19 4040

CStone Announces European Medicine Agency CHMP Recommends Approval of Cejemly® (sugemalimab, anti-PD-L1) as First-Line Treatment for NSCLC

* EMA CHMP recommendation is based on the results of a Phase 3 clinical trial (GEMSTONE-302) demonstrating significant progression-free survival (PFS) and overall survival (OS) benefits of sugemalimab in combination with chemotherapy as a first-line treatment for non-small cell lung cancer (NSC...

2024-06-02 08:24 3179

Innovent Presents at the 2024 ASCO Annual Meeting on Clinical Data of anti-CLDN18.2 ADC (IBI343) in Patients with Advanced Pancreatic Cancer or Biliary Tract Cancer

SAN FRANCISCO, U.S. and SUZHOU, China, June 2, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoi...

2024-06-02 08:00 4945

Innovent Announces Data from Pivotal Phase 2 TRUST-I Study of Taletrectinib（ROS1 Inhibitor) are Published in the JCO and Reported at 2024 ASCO Annual Meeting

SAN FRANCISCO, U.S. and SUZHOU, China, June 2, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoi...

2024-06-02 08:00 3051

Innovent Presents Phase 1 Clinical Data of First-in-class PD-1/IL-2α Bispecific Antibody Fusion Protein (IBI363) in Melanoma, Colorectal Cancer and other Solid Tumors at the 2024 ASCO Annual Meeting

SAN FRANCISCO, U.S. and SUZHOU, China, June 2, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmolog...

2024-06-02 08:00 3640

Mainland China